Champions Oncology Stock Price on December 18, 2024
| CSBR Stock | USD 8.35 0.25 3.09% |
Below is the normalized historical share price chart for Champions Oncology extending back to November 29, 1988. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Champions Oncology stands at 8.35, as last reported on the 28th of December, with the highest price reaching 8.46 and the lowest price hitting 7.54 during the day.
If you're considering investing in Champions Stock, it is important to understand the factors that can impact its price. Champions Oncology appears to be moderately volatile, given 3 months investment horizon. Champions Oncology secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19% return per unit of standard deviation over the last 3 months. By analyzing Champions Oncology's technical indicators, you can evaluate if the expected return of 0.99% is justified by implied risk. Please makes use of Champions Oncology's mean deviation of 3.7, and Risk Adjusted Performance of 0.1563 to double-check if our risk estimates are consistent with your expectations.
At this time, Champions Oncology's Common Stock Total Equity is relatively stable compared to the past year. As of 12/28/2024, Common Stock Shares Outstanding is likely to grow to about 14.2 M, while Treasury Stock is likely to drop (1.2 M). . As of 12/28/2024, Price To Sales Ratio is likely to drop to 1.24. In addition to that, Price Earnings Ratio is likely to grow to -8.58. Champions Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of January 2003 | 200 Day MA 4.8298 | 50 Day MA 4.9186 | Beta 0.493 |
Champions |
Sharpe Ratio = 0.1892
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CSBR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.23 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.99 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Champions Oncology is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Champions Oncology by adding it to a well-diversified portfolio.
Price Book 167.9675 | Enterprise Value Ebitda 82.6286 | Price Sales 2.2144 | Shares Float 4.8 M | Wall Street Target Price 8 |
Related Headline
Natera Headline on 18th of December 2024
Disposition of 303 shares by Sheena Jonathan of Natera at 16... by MacroaxisInsider
Filed transaction by Natera Inc Director, Other: Co-founder. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Champions Oncology Valuation on December 18, 2024
It is possible to determine the worth of Champions Oncology on a given historical date. On December 18, 2024 Champions was worth 6.58 at the beginning of the trading date compared to the closed value of 6.91. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Champions Oncology stock. Still, in general, we apply an absolute valuation method to find Champions Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Champions Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Champions Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 6.99 | 6.99 | 6.11 | 6.40 | 20,762 | |
12/18/2024 | 6.58 | 7.22 | 6.45 | 6.91 | 112,607 |
| 7.30 | 7.85 | 7.02 | 7.55 | 141,191 |
| Backtest Champions Oncology | | | Champions Oncology History | | | Champions Oncology Valuation | Previous | Next |
Champions Oncology Trading Date Momentum on December 18, 2024
| On December 19 2024 Champions Oncology was traded for 7.55 at the closing time. The top price for the day was 7.85 and the lowest listed price was 7.02 . The trading volume for the day was 141.2 K. The trading history from December 19, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 9.26% . The overall trading delta against the current closing price is 9.12% . |
Champions Oncology Fundamentals Correlations and Trends
By evaluating Champions Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Champions Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Champions financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Champions Oncology Stock history
Champions Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Champions is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Champions Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Champions Oncology stock prices may prove useful in developing a viable investing in Champions Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 13.5 M | 14.2 M | |
| Net Loss | -6.1 M | -6.4 M |
Champions Oncology Stock Technical Analysis
Champions Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Champions Oncology Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Champions Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Champions Oncology December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Champions Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Champions Oncology shares will generate the highest return on investment. By undertsting and applying Champions Oncology stock market strength indicators, traders can identify Champions Oncology entry and exit signals to maximize returns
Champions Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Champions Oncology's price direction in advance. Along with the technical and fundamental analysis of Champions Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Champions to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1563 | |||
| Jensen Alpha | 0.9475 | |||
| Total Risk Alpha | 0.7986 | |||
| Sortino Ratio | 0.2221 | |||
| Treynor Ratio | (3.39) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Champions Stock Analysis
When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.